2018 annual financial data
Sarepta Therapeutics 2018 Operating margin
Direct answer
Operating margin was -114.15%.
Operating income was -343,628,000 USD and net income was -361,918,000 USD.
Operating cash flow was -388,660,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 301,034,000 USD
- Operating income
- -343,628,000 USD
- Net income
- -361,918,000 USD
- Operating cash flow
- -388,660,000 USD